# EDGAR Filing Document

**Accession Number:** 0001705506
**File Stem:** 0001213900-25-083535
**Filing Date:** 2025-9
**Character Count:** 20567
**Document Hash:** 869f3768038b1245986563cd40937fd6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-083535.hdr.sgml**: 20250902

**ACCESSION NUMBER**: 0001213900-25-083535

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250828

**FILED AS OF DATE**: 20250902

**DATE AS OF CHANGE**: 20250902

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Gracias Antonio J.
- **CENTRAL INDEX KEY:** 0001495158

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39450
- **FILM NUMBER:** 251286816

**MAIL ADDRESS:**
- **STREET 1:** C/O VALOR EQUITY PARTNERS
- **STREET 2:** 200 SOUTH MICHIGAN AVENUE, SUITE 1020
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60604
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** VALOR EQUITY PARTNERS IV L.P.
- **CENTRAL INDEX KEY:** 0001705506

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39450
- **FILM NUMBER:** 251286819

**BUSINESS ADDRESS:**
- **STREET 1:** 875 NORTH MICHIGAN AVENUE
- **STREET 2:** SUITE 3214
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
- **BUSINESS PHONE:** (312) 683-1900

**MAIL ADDRESS:**
- **STREET 1:** 875 NORTH MICHIGAN AVENUE
- **STREET 2:** SUITE 3214
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** VALOR EQUITY PARTNERS IV-B L.P.
- **CENTRAL INDEX KEY:** 0001705512

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39450
- **FILM NUMBER:** 251286817

**BUSINESS ADDRESS:**
- **STREET 1:** 875 NORTH MICHIGAN AVENUE
- **STREET 2:** SUITE 3214
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
- **BUSINESS PHONE:** (312) 683-1900

**MAIL ADDRESS:**
- **STREET 1:** 875 NORTH MICHIGAN AVENUE
- **STREET 2:** SUITE 3214
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** VALOR EQUITY PARTNERS IV-A L.P.
- **CENTRAL INDEX KEY:** 0001705542

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39450
- **FILM NUMBER:** 251286818

**BUSINESS ADDRESS:**
- **STREET 1:** 875 NORTH MICHIGAN AVENUE
- **STREET 2:** SUITE 3214
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
- **BUSINESS PHONE:** (312) 683-1900

**MAIL ADDRESS:**
- **STREET 1:** 875 NORTH MICHIGAN AVENUE
- **STREET 2:** SUITE 3214
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Valor Equity Associates IV L.P.
- **CENTRAL INDEX KEY:** 0001822427

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39450
- **FILM NUMBER:** 251286820

**BUSINESS ADDRESS:**
- **STREET 1:** 875 N. MICHIGAN AVENUE
- **STREET 2:** SUITE 3214
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
- **BUSINESS PHONE:** (312) 568-4766

**MAIL ADDRESS:**
- **STREET 1:** 875 N. MICHIGAN AVENUE
- **STREET 2:** SUITE 3214
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Valor IV Pharma Holdings, LLC
- **CENTRAL INDEX KEY:** 0001821186

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39450
- **FILM NUMBER:** 251286823

**BUSINESS ADDRESS:**
- **STREET 1:** 875 N. MICHIGAN AVENUE
- **STREET 2:** SUITE 3214
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
- **BUSINESS PHONE:** (312) 568-4766

**MAIL ADDRESS:**
- **STREET 1:** 875 N. MICHIGAN AVENUE
- **STREET 2:** SUITE 3214
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Sabater Juan A.
- **CENTRAL INDEX KEY:** 0001821210

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39450
- **FILM NUMBER:** 251286815

**MAIL ADDRESS:**
- **STREET 1:** 630 W. GERMANTOWN PIKE
- **STREET 2:** SUITE 215
- **CITY:** PLYMOUTH MEETING
- **STATE:** PA
- **ZIP:** 19462
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Valor Equity Capital IV LLC
- **CENTRAL INDEX KEY:** 0001821936

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39450
- **FILM NUMBER:** 251286821

**BUSINESS ADDRESS:**
- **STREET 1:** 875 N. MICHIGAN AVENUE
- **STREET 2:** SUITE 3214
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
- **BUSINESS PHONE:** (312) 568-4766

**MAIL ADDRESS:**
- **STREET 1:** 875 N. MICHIGAN AVENUE
- **STREET 2:** SUITE 3214
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Valor Management L.P.
- **CENTRAL INDEX KEY:** 0001822428

**ORGANIZATION NAME:**
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39450
- **FILM NUMBER:** 251286822

**BUSINESS ADDRESS:**
- **STREET 1:** 875 N. MICHIGAN AVENUE
- **STREET 2:** SUITE 3214
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
- **BUSINESS PHONE:** (312) 568-4766

**MAIL ADDRESS:**
- **STREET 1:** 875 N. MICHIGAN AVENUE
- **STREET 2:** SUITE 3214
- **CITY:** CHICAGO
- **STATE:** IL
- **ZIP:** 60611
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Harmony Biosciences Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001802665
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 822279923
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 630 W GERMANTOWN PIKE
- **STREET 2:** SUITE 215
- **CITY:** PLYMOUTH MEETING
- **STATE:** PA
- **ZIP:** 19462
- **BUSINESS PHONE:** (484) 539-9800

**MAIL ADDRESS:**
- **STREET 1:** 630 W GERMANTOWN PIKE
- **STREET 2:** SUITE 215
- **CITY:** PLYMOUTH MEETING
- **STATE:** PA
- **ZIP:** 19462

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Valor IV Pharma Holdings, LLC<br><sub>(Last) (First) (Middle)</sub><br>320 N. SANGAMON<br>SUITE 1200<br><sub>(Street)</sub><br>CHICAGO, IL 60607<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-28 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Harmony Biosciences Holdings, Inc. [ HRMY ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Valor Management L.P.<br><sub>(Last) (First) (Middle)</sub><br>320 N. SANGAMON<br>SUITE 1200<br><sub>(Street)</sub><br>CHICAGO, IL 60611<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-28 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Harmony Biosciences Holdings, Inc. [ HRMY ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Valor Equity Capital IV LLC<br><sub>(Last) (First) (Middle)</sub><br>320 N. SANGAMON<br>SUITE 1200<br><sub>(Street)</sub><br>CHICAGO, IL 60611<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-28 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Harmony Biosciences Holdings, Inc. [ HRMY ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Valor Equity Associates IV L.P.<br><sub>(Last) (First) (Middle)</sub><br>320 N. SANGAMON<br>SUITE 1200<br><sub>(Street)</sub><br>CHICAGO, IL 60611<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-28 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Harmony Biosciences Holdings, Inc. [ HRMY ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>VALOR EQUITY PARTNERS IV L.P.<br><sub>(Last) (First) (Middle)</sub><br>320 N. SANGAMON<br>SUITE 1200<br><sub>(Street)</sub><br>CHICAGO, IL 60611<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-28 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Harmony Biosciences Holdings, Inc. [ HRMY ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>VALOR EQUITY PARTNERS IV-A L.P.<br><sub>(Last) (First) (Middle)</sub><br>320 N. SANGAMON<br>SUITE 1200<br><sub>(Street)</sub><br>CHICAGO, IL 60611<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-28 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Harmony Biosciences Holdings, Inc. [ HRMY ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>VALOR EQUITY PARTNERS IV-B L.P.<br><sub>(Last) (First) (Middle)</sub><br>320 N. SANGAMON<br>SUITE 1200<br><sub>(Street)</sub><br>CHICAGO, IL 60611<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-28 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Harmony Biosciences Holdings, Inc. [ HRMY ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Gracias Antonio J.<br><sub>(Last) (First) (Middle)</sub><br>C/O HARMONY BIOSCIENCES HOLDINGS, INC.<br>630 W GERMANTOWN PIKE, SUITE 215<br><sub>(Street)</sub><br>PLYMOUTH MEETING, PA 19462<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-28 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Harmony Biosciences Holdings, Inc. [ HRMY ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Sabater Juan A.<br><sub>(Last) (First) (Middle)</sub><br>630 W. GERMANTOWN PIKE<br>SUITE 215<br><sub>(Street)</sub><br>PLYMOUTH MEETING, PA 19462<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-28 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Harmony Biosciences Holdings, Inc. [ HRMY ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-08-28 |  | J<sup>(1)</sup> |  | 6618033 | D | <sup>(1)</sup> | 0 | D |  |
| Common Stock |  |  |  |  |  |  |  | 29497<sup>(2)</sup> | I | See Footnote<sup>(3)</sup> |
| Common Stock |  |  |  |  |  |  |  | 437619<sup>(2)</sup> | I | See Footnote<sup>(4)</sup> |
| Common Stock |  |  |  |  |  |  |  | 50423<sup>(2)</sup> | I | See Footnote<sup>(5)</sup> |
| Common Stock |  |  |  |  |  |  |  | 38275<sup>(2)</sup> | I | See Footnote<sup>(6)</sup> |
| Common Stock |  |  |  |  |  |  |  | 23714<sup>(2)</sup> | I | See Footnote<sup>(7)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) In-kind pro rata distribution by Valor IV Pharma Holdings, LLC, without consideration.

(2) Shares received in distribution described in footnote 1.

(3) Held by Valor Management L.P.

(4) Held by Antonio Gracias.

(5) Held by AJG Growth Fund LLC, an entity controlled by Mr. Gracias.

(6) Held by Juan Sabater.

(7) Held by Tamal, LLC, an entity controlled by Mr. Sabater.

**Remarks:**
Valor Funds Group LLC is the general partner of Valor Management L.P., which is the managing member of Valor Equity Capital IV LLC, which is the general partner of Valor Equity Associates IV L.P., which, in turn, is the general partner of limited partnerships (Valor Equity Partners IV L.P, Valor Equity Partners IV-A L.P. and Valor Equity Partners IV-B L.P.) that are the members of Valor IV Pharma Holdings, LLC. Antonio Gracias and Juan Sabater, each of whom is a director of the Issuer, may each be deemed to share beneficial ownership over the shares of the Issuer held by Valor IV Pharma Holdings, LLC by virtue of their positions with the above Valor entities; however, each disclaims beneficial ownership of the shares held by Valor IV Pharma Holdings, LLC.

**Signature:** Valor IV Pharma Holdings, LLC By: /s/ Antonio Gracias, Sole Manager  
**Date:** 2025-09-02

**Signature:** Valor Management L.P. By: /s/ Antonio Gracias, CEO  
**Date:** 2025-09-02

**Signature:** Valor Equity Capital IV LLC By: Valor Management L.P., its managing member By: /s/ Antonio Gracias, CEO  
**Date:** 2025-09-02

**Signature:** Valor Equity Associates IV L.P., By: Valor Equity Capital IV LLC, its general partner, By: Valor Management L.P., its managing member, By: /s/ Antonio Gracias, CEO  
**Date:** 2025-09-02

**Signature:** Valor Equity Partners IV, L.P., By: Valor Equity Associates IV L.P., By: Valor Equity Capital IV LLC, its general partner, By: Valor Management L.P., its managing member, By: /s/ Antonio Gracias, CEO  
**Date:** 2025-09-02

**Signature:** Valor Equity Partners IV-A, L.P., By: Valor Equity Associates IV L.P., By: Valor Equity Capital IV LLC, its general partner, By: Valor Management L.P., its managing member, By: /s/ Antonio Gracias, CEO  
**Date:** 2025-09-02

**Signature:** Valor Equity Partners IV-B, L.P., By: Valor Equity Associates IV L.P., By: Valor Equity Capital IV LLC, its general partner, By: Valor Management L.P., its managing member, By: /s/ Antonio Gracias, CEO  
**Date:** 2025-09-02

**Signature:** /s/ Antonio Gracias  
**Date:** 2025-09-02

**Signature:** /s/ Juan A. Sabater  
**Date:** 2025-09-02

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**